Legis Daily

Medicaid Pharmaceutical Home Act of 2018

USA115th CongressHR-5808| House 
| Updated: 6/12/2018
Gus M. Bilirakis

Gus M. Bilirakis

Republican Representative

Florida

Cosponsors (3)
Ben Ray Luján (Democratic)Marsha Blackburn (Republican)Greg Walden (Republican)

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Medicaid Pharmaceutical Home Act of 2018 This bill requires state Medicaid programs to establish drug-management programs for at-risk beneficiaries (those identified as at risk of abusing or misusing controlled substances).

Bill Text Versions

View Text
2 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 15, 2018
Introduced in House
May 15, 2018
Referred to the House Committee on Energy and Commerce.
May 17, 2018
Ordered to be Reported by Voice Vote.
May 17, 2018
Committee Consideration and Mark-up Session Held.
Jun 12, 2018
Placed on the Union Calendar, Calendar No. 561.
Jun 12, 2018
Reported by the Committee on Energy and Commerce. H. Rept. 115-726.
  • May 15, 2018
    Introduced in House


  • May 15, 2018
    Referred to the House Committee on Energy and Commerce.


  • May 17, 2018
    Ordered to be Reported by Voice Vote.


  • May 17, 2018
    Committee Consideration and Mark-up Session Held.


  • June 12, 2018
    Placed on the Union Calendar, Calendar No. 561.


  • June 12, 2018
    Reported by the Committee on Energy and Commerce. H. Rept. 115-726.

Health

Related Bills

  • HR 115-6: SUPPORT for Patients and Communities Act
Administrative remediesDrug, alcohol, tobacco useDrug trafficking and controlled substancesGovernment information and archivesHealth care costs and insuranceMedicaidMedicareMental healthPrescription drugsRetail and wholesale tradesRight of privacyState and local government operations

Medicaid Pharmaceutical Home Act of 2018

USA115th CongressHR-5808| House 
| Updated: 6/12/2018
Medicaid Pharmaceutical Home Act of 2018 This bill requires state Medicaid programs to establish drug-management programs for at-risk beneficiaries (those identified as at risk of abusing or misusing controlled substances).

Bill Text Versions

View Text
2 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 15, 2018
Introduced in House
May 15, 2018
Referred to the House Committee on Energy and Commerce.
May 17, 2018
Ordered to be Reported by Voice Vote.
May 17, 2018
Committee Consideration and Mark-up Session Held.
Jun 12, 2018
Placed on the Union Calendar, Calendar No. 561.
Jun 12, 2018
Reported by the Committee on Energy and Commerce. H. Rept. 115-726.
  • May 15, 2018
    Introduced in House


  • May 15, 2018
    Referred to the House Committee on Energy and Commerce.


  • May 17, 2018
    Ordered to be Reported by Voice Vote.


  • May 17, 2018
    Committee Consideration and Mark-up Session Held.


  • June 12, 2018
    Placed on the Union Calendar, Calendar No. 561.


  • June 12, 2018
    Reported by the Committee on Energy and Commerce. H. Rept. 115-726.
Gus M. Bilirakis

Gus M. Bilirakis

Republican Representative

Florida

Cosponsors (3)
Ben Ray Luján (Democratic)Marsha Blackburn (Republican)Greg Walden (Republican)

Energy and Commerce Committee

Health

Related Bills

  • HR 115-6: SUPPORT for Patients and Communities Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative remediesDrug, alcohol, tobacco useDrug trafficking and controlled substancesGovernment information and archivesHealth care costs and insuranceMedicaidMedicareMental healthPrescription drugsRetail and wholesale tradesRight of privacyState and local government operations